Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    " July 17, 2013":" August 16, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" July 17, 2013":" August 16, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Interventions: Drug: EVG;   Drug: Background regimen
2 Completed Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique
Condition: HIV-positive
Intervention: Behavioral: SMS reminders
3 Unknown  Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire
Condition: HIV Infection
Intervention:
4 Unknown  Safety and Immunological Response of a Boosting Dose of MVA-B in Healthy Volunteers After 4 Years of Receiving MVA-B
Condition: HIV Infections
Intervention: Biological: Experimental
5 Unknown  IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection
Condition: HIV Reservoirs
Intervention: Other: Blood sample and recto-colic biopsies
6 Completed Juvenile Detention to Community Life
Conditions: Substance Use;   Delinquency;   Risk for HIV Infection
Interventions: Behavioral: Multidimensional Family Therapy Cross-Systems;   Behavioral: Enhanced Services as Usual
7 Recruiting HBV-HIV Coinfection Research Network
Conditions: Hepatitis B;   Human Immunodeficiency Virus
Intervention:
8 Active, not recruiting A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir/abacavir/lamivudine FDC;   Drug: Atazanavir;   Drug: Ritonavir;   Drug: Tenofovir/emtricitabine FDC
9 Unknown  Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C
Conditions: Hepatitis C, Chronic;   HIV
Interventions: Drug: Pegylated interferon alpha-2a;   Drug: Ribavirin;   Drug: Boceprevir
10 Completed Male Engagement in PMTCT Services
Condition: HIV
Interventions: Other: clinic based intervention;   Other: clinic and community based intervention
11 Recruiting Study of Immune Responses Induced by a HIV Vaccine
Condition: HIV Infections
Interventions: Biological: AIDSVAX B/E;   Biological: AIDSVAX B/E Placebo
12 Active, not recruiting Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/E
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV;   Biological: AIDSVAX B/E;   Biological: ALVAC-HIV Placebo;   Biological: AIDSVAX B/E Placebo
13 Withdrawn Evaluating the Safety and Immune Response of DNA/MVA Vaccines in HIV-1-Infected Young Adults Taking Anti-HIV Medications
Condition: HIV Infections
Interventions: Biological: GEO-D03 DNA Vaccine;   Biological: MVA/HIV62B Vaccine;   Biological: Placebo for DNA GEO-D03;   Biological: Placebo for MVA/HIV62B Vaccine
14 Recruiting RCT of an Integrative Intervention for Non-Treatment-Seeking Meth Users
Conditions: HIV/AIDS;   Stimulant Use Disorders
Interventions: Behavioral: Affect Regulation Treatment to Enhance Meth Intervention Success (ARTEMIS);   Behavioral: Contingency Management (CM)
15 Completed Evaluating the Effectiveness of Point-of-care Diagnostic Technologies in MCH Services in Mozambique
Conditions: HIV;   Syphilis;   Anemia During Pregnancy
Interventions: Device: PIMA® for quantitative analysis of CD4-count;   Device: Hemocue® (HemoCue AB, Angelhom, Sweden) for quantitative analysis of hemoglobin;   Device: SD Bioline® (Standard Diagnostics Inc., South-Korea) for qualitative analysis of syphilis
16 Unknown  The ACCLAIM Project
Condition: HIV
Interventions: Behavioral: Community leader engagement;   Behavioral: Community days;   Behavioral: Community Peer Groups
17 Active, not recruiting ENhance Initiation and Retention in Isoniazid Preventive Therapy (IPT) Care for HIV Study (ENRICH Study)
Conditions: HIV;   Tuberculosis
Interventions: Behavioral: Combination intervention components;   Drug: Isoniazid Prevention Therapy
18 Recruiting Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone
Conditions: Immune Reconstitution Inflammatory Syndrome;   HIV;   Tuberculosis
Interventions: Drug: Prednisone;   Drug: Placebo
19 Recruiting Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia
Conditions: Anal Intraepithelial Neoplasia;   HIV
Intervention: Drug: HPV-16 vaccine
20 Recruiting Maternal HIV: Trial to Assist Disclosure to Children
Condition: HIV
Intervention: Behavioral: TRACK Intervention

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Indicates status has not been verified in more than two years